23
Feb
Merck Bids $1.75 for Viralytics

Merck (NYSE:MRK) and Viralytics announced overnight the agreed acquisition of Viralytics by Merck for A$1.75 cash. The stock last traded at 63 cents prior to the announcement. VLA hit a high of $1.26 in December 2016.

22
Feb
QUEST AGAIN A LONSEC FINALIST

Quest Asset Partners are a finalist in the Lonsec Fund Manager Awards for the second year in a row.

08
Sep
Bingo Cleans Up On First Result

The market liked the first result from Bingo Industries (BIN) delivered in mid August. Prior to the result, Bingo traded at $1.87 but has shifted up a level to $2.20 currently.

19
Jul
Summary of Fiscal 2017

The Quest Australian Equities Concentrated Portfolio has concluded a strong fiscal 2017 with a pre fees return of 18.6%. This is 4.8% ahead of the ASX 300 Accumulation.